Kraszewska Agnieszka, Ziemnicka Katarzyna, Jończyk-Potoczna Katarzyna, Sowiński Jerzy, Rybakowski Janusz K
Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.
Hum Psychopharmacol. 2019 Jul;34(4):e2708. doi: 10.1002/hup.2708. Epub 2019 Jul 11.
The aim of the study was to compare the structure and function of the thyroid in patients with bipolar disorder (BD) receiving long-term lithium treatment, with BD patients never receiving lithium.
Ninety-eight patients (68 female and 30 male), aged 62 ± 13 years, receiving lithium for 3-47 years (mean 19 ± 10 years), and 39 patients (27 female and 12 male), aged 57 ± 10 years, receiving other mood-stabilizing drugs but never treated with lithium, were included. The thyroid-stimulating hormone (TSH), free triiodothyronine (fT3), and free thyroxine (fT4) were estimated, and the ultrasonographic study of the thyroid gland was performed.
Compared with patients not receiving lithium, lithium-treated patients had significantly higher concentrations of TSH and fT4 and the lower concentration of fT3. However, the percentage of hypothyroidism was not different in both groups. Lithium-treated patients also had significantly higher thyroid volume, the higher number of focal changes >1 cm, and more frequent goiter. The structural changes were not related to the hormones' concentrations.
The results show a significant association between long-term lithium treatment and the increase of TSH and fT4, the decrease of fT3, higher thyroid volume, and more frequent goiter and nodular goiter. The effect of lithium on thyroid structure was not associated with its effect on thyroid hormones.
本研究旨在比较长期接受锂盐治疗的双相情感障碍(BD)患者与从未接受锂盐治疗的BD患者甲状腺的结构和功能。
纳入98例患者(68例女性和30例男性),年龄62±13岁,接受锂盐治疗3 - 47年(平均19±10年),以及39例患者(27例女性和12例男性),年龄57±10岁,接受其他心境稳定剂治疗但从未接受锂盐治疗。测定促甲状腺激素(TSH)、游离三碘甲状腺原氨酸(fT3)和游离甲状腺素(fT4),并对甲状腺进行超声检查。
与未接受锂盐治疗的患者相比,接受锂盐治疗的患者TSH和fT4浓度显著升高,fT3浓度降低。然而,两组甲状腺功能减退的百分比无差异。接受锂盐治疗的患者甲状腺体积也显著增大,直径>1 cm的局灶性改变数量更多,甲状腺肿更常见。结构变化与激素浓度无关。
结果显示长期锂盐治疗与TSH和fT4升高、fT3降低、甲状腺体积增大、甲状腺肿和结节性甲状腺肿更常见之间存在显著关联。锂盐对甲状腺结构的影响与其对甲状腺激素的影响无关。